Conference archive

National OPAT Conference 2018

You will find links to the slide sets and poster presentations below.

13 December

Welcome and Opening Remarks

Mr Mark Gilchrist

SESSION ONE: CAN I TELL YOU A STORY?

My OPAT journey - a younger person's perspective, Question and Answer sessions

Mr Thomas Mallet

SESSION TWO: OPAT CHALLENGES IN SPECIFIC CONDITIONS

OPAT via telemedicine (Presentation via Skype)

Dr Paul Ingram

Defining the positive outcome - OPAT in palliative care

Dr Eoghan de Barra

Managing Staphylococcal Bacteraemias

Sanjita Brito-Mutunayagam

The challenge of orthopaedic infections in the post OVIVA era

Dr Bridget Atkins

SESSION THREE: DELIVERING SAFER OPAT

Good Practice Recommendations - the key learning points

Dr Ann Chapman

Using OPAT to drive paediatric stewardship

Dr Sanjay Patel & Miss Emily Tanner

Beyond the OPAT MDT: hazards and opportunities

Dr Andrew Seaton

DEBATE: OPAT COMPETENCIES - NEEDED OR NOT?

Speaking in favour

Dr Sue Snape

Speaking against

Dr Sarah Logan

SESSION FIVE: DRUGS & DEVICES

Outpatient management of complex oral antibiotic regimens

Ms Julie Statham

ECG directed PICC line insertion

Mrs Elizabeth Wilson

Vascular health management in children

Miss Ruth Cantwell

A comparison of bolus versus infusion administration of ceftraiaxone in patients under OPAT

Miss Lucille Mclean

Evaluating the safety of antibiotic administration using elastomeric devises in children managed within a tertiary paediatric OPAT service

Mrs Jacqueline Gray

SESSION SIX: LESSONS AND DILEMMAS FROM THE REGIONS

Setting up an in house elastomeric device service for OPAT

Dr Sue Snape

Role of OPAT in hemodialysis

Dr Carolyn Hemsley

Vascular graft infection and OPAT

Dr Fiona Andrewartha

Tubo-ovarian abscess and OPAT

Dr James Hatcher

Nurse led management of SSTIs

Ms Claire Vallance

SESSION SEVEN: NATIONAL DISCUSSION FORUM

Facilitated discussion addressing issues raised by delegates

Panel comprising: Mr Mark Gilchrist, Dr Andrew Seaton, Dr Sanjay Patel, Mrs Liz Wilson & Dr Ann Chapman

14 December

SESSION EIGHT: INTERACTIVE CLINICAL CASE STUDIES

Case Study 1: UBI PUS, IBI EVAQUA & Case Study 2: Double Trouble

Dr Chris Lynch

Case Study 3: Bacteraemia, Haemodialysis and OPAT

Dr Hector Maxwell-Scott

Case Study 4: Bacteraemia, Haemodialysis and OPAT

Dr Anna Goodman

SESSION TEN: KEYNOTE LECTURE

Role of extended dosing interval antimicrobials in OPAT

Dr Urania Rappo

SESSION ELEVEN: INVITED PAPERS

Colour coded classification of OPAT patients as an alternative model of care

Ms Julie Statham

Developing a Risk Prediction Model for 30-Day Unplanned Hospitalisation in Patients Receiving Outpatient Parenteral Antimicrobial Therapy

Dr Chris Durojaiye

Identifying risk factors for non-completion of OPAT course to enable intervention before and during home treatment

Dr Ian Miskin

Using NORS data to optimise duration of antibiotic therapy in OPAT

Dr John Williams

A systematic review of Human Factors identified from Outpatient Parenteral Antimicrobial Therapy research using the SEIPS 2.0 model

Mrs Sara Jo Bugeja

SESSION TWELVE: INFORMING THE FUTURE AGENDA

Measuring practice and outcomes - Registry outputs and what they mean

Mr Mark Gilchrist

UK Drug Stability Testing Programme - outputs and future aspirations

Dr Conor Jamieson

OPAT 2019 and beyond

Mr Mark Gilchrist

When

13-14 DECEMBER 2018

Where

QEII CONFERENCE CENTRE, LONDON

Thank you

Thank you for attending. This event was a massive success bringing together over 200 OPAT experts to share their expertise, discuss success stories and learn about upcoming challenges in the OPAT setting.

We look forward to seeing you at the National OPAT Conference 2019.

Top